<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107587">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01918163</url>
  </required_header>
  <id_info>
    <org_study_id>0059-13HYMC</org_study_id>
    <nct_id>NCT01918163</nct_id>
  </id_info>
  <brief_title>Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility.</brief_title>
  <acronym>Pomegranate</acronym>
  <official_title>Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <authority>Israel: The Israel National Institute for Health Policy Research and Health Services Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Some animal studies revealed that the pomegranate juice may improve sperm quality in terms
      of concentration, motility and morphology, as well as in fertilization rate.

      Minor data is available regarding the influence on male sperm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pomegranate contains a high concentration of vitamins ( C,   B1,   B2,   B3,   B5),
      potassium, Magnesium , Zinc and is a good source for polyphenols .Polyphenols molecules have
      been found to possess antioxidant properties and may effects the expression of different
      genes . Recent studies indicate that among foods that contain polyphenols, juice extracted
      from the pomegranate has the highest concentration of measurable polyphenols . Pomegranates
      have shown inhibitory effect on NF-κB and the MAP kinases JNK and ERK, which are critical
      steps in the cascade of events leading to inflammatory response. The NF- κB pathway is
      activated in response to bacterial infection and initiates the inflammatory cascade, which
      may explain the protective effect of Pomegranates on bacterial infections.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>pregnancy</measure>
    <time_frame>24 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>ROS (reactive oxidative stress )and Interleukins level in semen fluid</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The unit for measure the ROS are Micromolar epicatechin equivalent</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Male Infertility With Severe Oligo-terato-asteno-spermia</condition>
  <arm_group>
    <arm_group_label>No Pills</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will not receive Pomegranate pills.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pomegranate pills</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The reccruited patient will receive pomegranate pills every day for 12 weeks. The control group will not be exposed for the pills.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Pomegranate pills</intervention_name>
    <arm_group_label>Pomegranate pills</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  TMC  of less than 5 million spermatogonia in native sperm and morphology less than 4%
             by Kruger criteria.

        Exclusion Criteria:

          -  sensitivity to Pomegranate
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Einat Shalom-Paz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hillel Yaffe Medical center, IVF unit, Hadera, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Einat Shalom-Paz, MD</last_name>
    <phone>972544899155</phone>
    <email>einatshalompaz@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ellenbogen Adrian, MD</last_name>
    <phone>973506246722</phone>
    <email>ellenbogen@hy.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reuma Barkan</last_name>
      <phone>97246304223</phone>
      <email>reuma@hy.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>August 6, 2013</lastchanged_date>
  <firstreceived_date>July 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pomegranate pills, male infertility, pregnancy rate, semen analysis, ROS, oxidative stress</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Contraceptives, Oral</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
